Shares of Microchip Technology cratered as much as 13.9% after the chipmaker delivered a strong September quarter but issued December-quarter guidance that landed below Wall Street expectations, forcing investors to reckon with a growth story that may be hitting temporary speed bumps — or something worse.
A Solid Quarter Inflated by $53 Million That Won't Repeat
Net sales of $1.622 billion topped the company's own guidance midpoint of $1.604 billion , and non-GAAP earnings of $0.97 per share beat the consensus estimate of $0.93 . But buried in the results were $53 million in one-time items — $21 million from pricing adjustments on distributor inventory, $22 million from patent licensing deals, and $10 million from a long-term customer contract . Strip those out, and the beat shrinks considerably. That distinction matters because Q3 guidance remains conservative, reflecting the absence of that $53 million in one-time revenue .
The Guidance Gap Spooked a Market Priced for Acceleration
Microchip guided Q3 net sales to $1.573 billion–$1.638 billion and non-GAAP EPS of $0.87–$0.95 — a midpoint of roughly $1.606 billion and $0.91, versus consensus of $1.62 billion and $0.94. Management said capacity constraints are pushing some shipments into the March quarter , and non-GAAP gross margins are expected to fall to 64%–65% , down from 66.5% in Q2. For a stock that had rallied sharply on recovery momentum, even a modest miss triggered a dramatic repricing.
Analysts Cut Targets but Mostly Held Their Ground
Cantor Fitzgerald cut its target from $125 to $100, Needham trimmed from $120 to $85, Rosenblatt lowered from $120 to $115, Mizuho reduced from $112 to $90, Susquehanna cut from $120 to $100, and Truist slashed from $90 to $62 . Despite the cuts, most analysts maintained constructive ratings, with consensus sitting at "Moderate Buy" and an average target of $94.62 — still 67% above the current price near $56.72.
Edge AI Bets Add Cost Now, Revenue Later
Net debt fell $31.7 million even after funding the Hailo acquisition, which management says accelerated its AI-at-the-edge roadmap by five years . But while the deal already has a "multi-hundred million dollar funnel," Microchip must absorb Hailo's higher R&D spending in the near term . The payoff is real but distant, and today's investors are clearly demanding proof, not promises.